The relative burden of diabetes complications on healthcare costs: the population-based CINECA-SID ARNO Diabetes Observatory
E Pagano, M De Rosa, E Rossi, E Cinconze… - Nutrition, Metabolism …, 2016 - Elsevier
Background and aims In the present population-based study, we aimed to describe the per
patient annual healthcare cost of people with diabetes in 2007–2012, to assess the relative …
patient annual healthcare cost of people with diabetes in 2007–2012, to assess the relative …
Consensus document ANMCO/ANCE/ARCA/GICR-IACPR/GISE/SICOA: long-term antiplatelet therapy in patients with coronary artery disease
Dual antiplatelet therapy (DAPT) with aspirin and a P2Y12 receptor inhibitor is the
cornerstone of pharmacologic management of patients with acute coronary syndrome (ACS) …
cornerstone of pharmacologic management of patients with acute coronary syndrome (ACS) …
A Systematic Review of Case-Identification Algorithms Based on Italian Healthcare Administrative Databases for Three Relevant Diseases of the Cardiovascular …
BACKGROUND: acute myocardial infarction (AMI), ischemic heart diseases (IHDs) and
stroke are serious cardiovascular diseases (CVDs) which may lead to hospitalizations …
stroke are serious cardiovascular diseases (CVDs) which may lead to hospitalizations …
Appropriateness of antiplatelet therapy for primary and secondary cardio‐and cerebrovascular prevention in acutely hospitalized older people
I Ardoino, R Rossio, D Di Blanca… - British journal of …, 2017 - Wiley Online Library
Aims Antiplatelet therapy is recommended for the secondary prevention of cardio‐and
cerebrovascular disease, but for primary prevention it is advised only in patients at very high …
cerebrovascular disease, but for primary prevention it is advised only in patients at very high …
[HTML][HTML] Effect of nicorandil combined with trimetazidine on miR-223-3p and NRF2 expression in patients with coronary heart disease
Y Wu, Y Fan, N Huang, S Zhang, H Zhang… - American Journal of …, 2021 - ncbi.nlm.nih.gov
Objective: The aim of this study was to explore the effect of nicorandil (NCR) combined with
trimetazidine (TMZ) on miR-223-3p and NRF2 expression in patients with coronary heart …
trimetazidine (TMZ) on miR-223-3p and NRF2 expression in patients with coronary heart …
[PDF][PDF] High thrombotic risk increases adverse clinical events up to 5 years after acute myocardial infarction. A nationwide retrospective cohort study
GF Mureddu, C Greco, S Rosato… - … Archives for Chest …, 2019 - monaldi-archives.org
The risk of recurrent events among survivors of acute myocardial infarction (AMI) is
understudied. The aim of this analysis was to investigate the role of residual high thrombotic …
understudied. The aim of this analysis was to investigate the role of residual high thrombotic …
[PDF][PDF] Documento di consenso intersocietario ANMCO/ANCE/ARCA/GICR-IACPR/GISE/SICOA: La terapia antiaggregante a lungo termine nel paziente con malattia …
Although current European Society of Cardiology guidelines provide backup to individualize
treatment, it seems difficult to identify the ideal patient profile who could safely reduce or …
treatment, it seems difficult to identify the ideal patient profile who could safely reduce or …
The use of antiplatelet medication in hospitalised elderly patients.
M Wawruch, V Slezakova, J Murin… - Bratislavske Lekarske …, 2015 - europepmc.org
Background The use of antiplatelet agents is strongly recommended for the secondary
prevention of ischemic events such as myocardial infarction, stroke/transient ischemic attack …
prevention of ischemic events such as myocardial infarction, stroke/transient ischemic attack …
[HTML][HTML] Impact of Age, Multimorbidity and Frailty on the Prescription of Preventive Antiplatelet Therapy in Older Population
C Laborde, J Barben, AM Mihai, V Nuss… - International Journal of …, 2020 - mdpi.com
Platelet aggregation inhibitors (PAI) have widely proven their efficiency for the prevention of
ischemic cardiovascular events. We aimed to describe PAI prescription in an elderly …
ischemic cardiovascular events. We aimed to describe PAI prescription in an elderly …
[PDF][PDF] UFR des Sciences de Santé Circonscription Médecine
C LABORDE - 2017 - nuxeo.u-bourgogne.fr
Les maladies cardio-vasculaires (MCV) représentent 45% des causes de décès en Europe,
entrainant plus de 4 millions de morts par an dont 65% surviennent après 65ans (1). L'âge …
entrainant plus de 4 millions de morts par an dont 65% surviennent après 65ans (1). L'âge …